Injection of Glatiramer Acetate Depot Results in T1 and T2 Lesion Reduction in Relapsing MS.

Published Date: 01 Mar 2023

Secondary results from a phase 3 study show that patients with multiple sclerosis receiving glatiramer acetate depot therapy have significantly fewer new T1 enhancing lesions and new, enlarging hyperintense T2 lesions.

Read Full News

Latest News

Young Woman Lost for Words Months After Stillbirth

Coexisting headache, blurred vision and nausea offer diagnostic clues

Kennedy's New Autism Research Program Aims to Speed Diagnoses

— ARPA-H launches SPECTRA autism research initiative

Gabapentin Use Rose as Restrictions Fell, Study Shows

Descheduling gabapentin in Michigan was tied to an immediate increase in dispensing

The Paradigm Shift in Neuro-Oncology: Precision Decision-Making for IDH1/2 Mutated Gliomas

The Paradigm Shift in Neuro-Oncology: Precision Decision-Making for IDH1/2 Mutated Gliomas

All that Glitters Isn't Gold: An Exploration of Parkinson's Disease Mimics

All that Glitters Isn't Gold: An Exploration of Parkinson's Disease Mimics

FDA Clears Blood Test to Detect Alzheimer's in Primary and Specialty Care

Assay measures phosphorylated tau 217, an indicator of amyloid pathology

Todays Updates

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Ureteroscopy and histopathology should be considered as routine preoperative assessments

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Todays Updates

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Ureteroscopy and histopathology should be considered as routine preoperative assessments

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Latest News

Coexisting headache, blurred vision and nausea offer diagnostic clues

— ARPA-H launches SPECTRA autism research initiative

Descheduling gabapentin in Michigan was tied to an immediate increase in dispensing

The Paradigm Shift in Neuro-Oncology: Precision Decision-Making for IDH1/2 Mutated Gliomas

All that Glitters Isn't Gold: An Exploration of Parkinson's Disease Mimics

Assay measures phosphorylated tau 217, an indicator of amyloid pathology

News All Time

1,081 Injuries Tied to Device; Military's COVID Shot Probe; Teen Vax Coverage Slides

Health news and commentary gathered by MedPage Today staff

Rare Brain Disorder Gets Its First FDA Drug Approval

Zilganersen targets protein buildup that drives Alexander disease

Parkinson's Risk and Carbon Monoxide: What a New Study Found

Analysis offers surprising twist to the smoking-Parkinson's puzzle

Iron, Selenium, and Dementia; Epilepsy and Education; Brain Death Conversations

News and commentary from the world of neurology and neuroscience

MS Drugs Differ Most on Relapses, Not Disability, Real-World Study Shows

In new patients, disability score changes were similar over 2 years regardless of treatment

Autism Tied to 14-Year Gap in Life Expectancy

Large U.S. study points to preventable causes of excess mortality

Trial Confirms IVIG as Useful Therapy for Inflammatory Myopathy

But thromboembolic risks could be significant

First Therapy to Target Muscle Loss in Spinal Muscular Atrophy Gets FDA Approval

Motor function may improve with adjunctive apitegromab

Alzheimer's and Liver Enzymes; Pivotal Trial Hold; Lasker Awards Honor Brain Science

News and commentary from the world of neurology and neuroscience

Aging Doctors Face a Patchwork of Cognitive Screening Policies, Study Shows

Unlike pilots, judges, and air traffic controllers, physicians rely largely on self-regulation

Trump's Surgeon General Pick Grilled Over Vaccine Stance

"I do not believe childhood vaccines cause autism," Saphier said

Case Report: What Caused This Man's Acute Paralysis?

36-year-old Asian man had epidural steroid injection for persistent back pain after unsuccessful chiropractic treatments

Man Presents With Episodic, One-Sided Facial Paralysis

Uncommon presentation of MS detailed in case report

FDA-Ordered Studies for Drugs and Devices on the Market for Years Still Aren't Done

Agency's reliance on postmarketing studies reflects a balancing act

Gene Therapy for Sanfilippo Syndrome Gets FDA Nod

Treatment is the first for MPS type IIIA

Depression Drug Trials Paused Over Side-Effect Concerns

Xenon Pharmaceuticals on Thursday said it has temporarily paused enrolling new patients in clinical studies testing ⁠its experimental drug for major and bipolar depression,...

Recommended News For You

New target points to combination therapy for thwarting multidrug resistance in cancer treatment

Trial Challenges Indefinite Maintenance for Multiple Myeloma

'Sleep ALL night' program helps children with leukemia sleep better during treatment

Stem Cell Transplant Linked to Longer Survival in CMML

Win for Perioperative Durvalumab in Muscle-Invasive Bladder Cancer

Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.

UK Lawmakers Reject Bid to Legalise Assisted Dying

Recommended Articles For You

Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment 

How AI is Transforming Diagnostics, Drug Discovery, and Personalized Oncology 

Building Bridges between Heart and Cancer Care: A Comprehensive Guide to Cardio-Oncology Clinics 

Innovative Advances in Oncology for Specialists 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

For incarcerated people, study shows gaps exist in quality of cancer care

2.

Video: How to treat kidney disease?

3.

FDA Expands Approval of Osimertinib in Lung Cancer

4.

Is Shorter Radiation Linked to Lymphedema in Breast Cancer?

5.

Despite Medicare Coverage, Cancer Genomic Testing Still Low

1.

Immune Landscape Evolution in the Tumor Stromal Ecosystem

2.

Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide 

3.

Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates

4.

Quality of Life Following Organ Function Preserving Oncologic Innovation

5.

Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Expert Perspectives on Hematology

2.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

5.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot